Health hazard evaluation determination report: HHE-77-43-500, Shell Oil Refinery, Deer Park, Texas.
Authors
Wisseman C; Xintaras C; Hollett B
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HHE 77-43-500, 1978 Jun; :1-67
Medical surveys and environmental sampling were conducted to evaluate the association between methyl-ethyl-ketone (78933) (MEK) and toluene (108883) exposure and the incidence of peripheral neuropathy in workers in the Lube B Dewaxing Unit at the Shell Oil Refinery (SIC-2911) in Deer Park, Texas. The evaluation was requested by an authorized employee representative of the Oil, Chemical and Atomic Workers International Union, Local 4-367, and by the corporate medical director of Shell on behalf of an unspecified number of affected employees. Neuropathies were mild and were manifested more by discomfort than by functional impairment. Industrial hygiene data from OSHA and Shell did not reveal the presence of any known cause of peripheral neuropathies. MEK and toluene were generally found at concentrations below 20 parts per million. The authors conclude that a possible excess of mild peripheral neuropathy exists among employees in the Lube B Dewaxing Unit, that the cause of the observed neuropathies cannot be determined, that the prevalence of overt diabetes mellitus and elevated serum triglyceride is not excessive and that the prevalence of subclinical diabetes may be excessive. They recommend that exposure to MEK and toluene be minimized in view of their possible role in causing neuropathy.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.